NCT04549701View on ClinicalTrials.gov

Inferior Vena CAVA and Lung UltraSound-guided Therapy in Acute Heart Failure

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 20, 2022

Primary Completion Date

January 31, 2023

Study Completion Date

February 28, 2023

Conditions
Heart FailureAcute Heart Failure
Interventions
OTHER

CAVAL US-guided Therapy

Patients randomly assigned to this group will receive a daily CAVAL US exam guided decongestive therapy accessible to treating medical team, in addition to the standard care.

OTHER

Standard of care

Standard of care will be provided.

Trial Locations (2)

1428

Instituto Cardiovascular de Buenos Aires, Buenos Aires

Instituto Cardiovascular de Buenos Aires, Buenos Aires

All Listed Sponsors
lead

Instituto Cardiovascular de Buenos Aires

OTHER